Xanthone constituents of the fruits of garcinia mangostana with anticomplement activity

Phytotherapy Research

Volumn 24, Issue 10, 2010, Pages 1575-1577

  Quan, Gui Hua ^a   Oh, Sei Ryang ^a   Kim, Jung Hee ^a   Lee, Hyeong Kyu ^a   Kinghorn, A Douglas ^b   Chin, Young Won ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

1 isomangostin; anticomplement activity; Garcinia mangostana; garcinone E; xanthones

Indexed keywords

1 ISOMANGOSTIN; ALPHA MANGOSTIN; GAMA MANGOSTIN; GARCINIA MANGOSTANA EXTRACT; GARCINONE E; GARTANIN; PLANT EXTRACT; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ARTICLE; COMPLEMENT INHIBITION; FRUIT; GARCINIA MANGOSTANA; HUMAN; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

COMPLEMENT INACTIVATING AGENTS; FRUIT; GARCINIA MANGOSTANA; MOLECULAR STRUCTURE; XANTHENES; XANTHONES;

GARCINIA MANGOSTANA;

EID: 78649440590     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3177     Document Type: Article

References (14)

1. Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD., 2008. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod 71: 1161-1166.
2. Chen L-G, Yang L-L, Wang C-C., 2008. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 46: 688-693.
3. Chin Y-W, Kinghorn AD., 2008. Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini Rev Org Chem 5: 355-364.
4. Han AR, Kim JA, Lantvit DD, et al,. 2009. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod 72: 2028-2031.
5. Ho C-K, Huang Y-L, Chen C-C., 2002. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Med 68: 975-979.
6. Jung KY, Oh SR, Park SH, et al,. 1998. Anti-complementary activity of tiliroside from the flower buds of Magnolia fargesii. Biol Pharm Bull 21: 1077-1078.
7. Kim DS, Oh SR, Lee IS, et al,. 1998. Anticomplementary activity of ginseng saponins and their degradation products. Phytochemistry 47: 397-399.
8. Mahabusarakam W, Wiriyachitra P, Taylor WC., 1987. Chemical constituents of Garcinia mangostana. J Nat Prod 50: 474-478.
9. Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M., 2009. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 23: 1047-1065.
10. Park BY, Min BS, Oh SR, et al,. 2004. Isolation and anticomplement activity of compounds from Dendropanax morbifera. J Ethnopharmacol 90: 403-408.
11. Qu H, Ricklin D, Lambris JD., 2009. Recent developments in low molecular weight complement inhibitors. Mol Immunol 47: 185-195.
12. Sakai S, Katsura M, Takayama H, Aimi N, Chokethaworn N, Suttajit M., 1993. The structure of garcinone E. Chem Pharm Bull 41: 958-960.
13. Shankaranarayan D, Gopalakrishnan C, Kameswaran L., 1979. Pharmacological profile of mangostin and its derivatives. Arch Int Pharmacodyn Ther 239: 257-269.
14. Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A., 2006. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull 54: 301-305.